☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Inhaled Insulin discontinued

According to an article on the PharmaTimes website, Inhaled Insulin marketed as Exubera® is being pulled from the market for commercial reasons.

Despite some heavy promotional activity the product has failed to make any impact in the diabetes market. According to PharmaTimes, this decision will cost the manufacturer $2.8 billion in terms of current inventory stock, fixed assets and exit costs in addition to the $1.3 billion already paid back in 2006 to ensure sole marketing rights to the drug.

Action: Patients who are currently being treated with inhaled insulin will need to be moved to an alternative treatment within the next three months.

Share 'Inhaled Insulin discontinued' by emailShare 'Inhaled Insulin discontinued' on FacebookShare 'Inhaled Insulin discontinued' on TwitterShare 'Inhaled Insulin discontinued' on LinkedInShare 'Inhaled Insulin discontinued' on reddit


No Comments to “Inhaled Insulin discontinued”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.